SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size 2/24/17 Physicians Realty Trust 10-K 12/31/16 112:31M Physicians Realty L.P. |
Document/Exhibit Description Pages Size 1: 10-K Annual Report HTML 2.88M 2: EX-10.9 Material Contract HTML 102K 5: EX-21.1 Subsidiaries List HTML 77K 6: EX-23.1 Consent of Experts or Counsel HTML 30K 7: EX-23.2 Consent of Experts or Counsel HTML 30K 3: EX-12.1 Statement re: Computation of Ratios HTML 46K 4: EX-12.2 Statement re: Computation of Ratios HTML 47K 8: EX-31.1 Certification -- §302 - SOA'02 HTML 36K 9: EX-31.2 Certification -- §302 - SOA'02 HTML 36K 10: EX-31.3 Certification -- §302 - SOA'02 HTML 36K 11: EX-31.4 Certification -- §302 - SOA'02 HTML 36K 12: EX-32.1 Certification -- §906 - SOA'02 HTML 33K 13: EX-32.2 Certification -- §906 - SOA'02 HTML 33K 20: R1 Document and Entity Information HTML 63K 21: R2 Consolidated Balance Sheets HTML 174K 22: R3 Consolidated Balance Sheets (Parenthetical) HTML 54K 23: R4 Consolidated Statements of Operations HTML 201K 24: R5 Consolidated Statements of Comprehensive Income HTML 60K Statement 25: R6 Consolidated and Combined Statement of Equity HTML 106K 26: R7 Consolidated Statements of Changes in Capital HTML 136K 27: R8 Consolidated Statements of Cash Flows HTML 263K 28: R9 Organization and Business HTML 85K 29: R10 Summary of Significant Accounting Policies HTML 145K 30: R11 Acquisitions and Dispositions HTML 509K 31: R12 Intangibles HTML 112K 32: R13 Other Assets HTML 46K 33: R14 Debt HTML 99K 34: R15 Derivatives HTML 48K 35: R16 Accrued Expenses and Other Liabilities HTML 47K 36: R17 Stock-based Compensation HTML 107K 37: R18 Fair Value Measurements HTML 69K 38: R19 Tenant Operating Leases HTML 39K 39: R20 Rent Expense HTML 42K 40: R21 Credit Concentration HTML 62K 41: R22 Earnings Per Share and Earnings Per Unit HTML 107K 42: R23 Subsequent Events HTML 46K 43: R24 Quarterly Data HTML 167K 44: R25 Schedule Iii - Real Estate and Accumulated HTML 1.87M Depreciation 45: R26 Summary of Significant Accounting Policies - HTML 189K (Policies) 46: R27 Organization and Business - (Tables) HTML 72K 47: R28 Summary of Significant Accounting Policies - HTML 80K (Tables) 48: R29 Acquisitions and Dispositions - (Tables) HTML 509K 49: R30 Intangibles - (Tables) HTML 113K 50: R31 Other Assets - (Tables) HTML 46K 51: R32 Debt - (Tables) HTML 87K 52: R33 Derivatives - (Tables) HTML 37K 53: R34 Accrued Expenses and Other Liabilities - (Tables) HTML 47K 54: R35 Stock-based Compensation - (Tables) HTML 92K 55: R36 Fair Value Measurements - (Tables) HTML 64K 56: R37 Tenant Operating Leases - (Tables) HTML 37K 57: R38 Rent Expense - (Tables) HTML 37K 58: R39 Credit Concentration - (Tables) HTML 64K 59: R40 Earnings Per Share and Earnings Per Unit - HTML 105K (Tables) 60: R41 Subsequent Events - (Tables) HTML 44K 61: R42 Quarterly Data - (Tables) HTML 162K 62: R43 Organization and Business - (Details) HTML 78K 63: R44 Organization and Business - Schedule of Issuance HTML 55K and Sale of Common Stock (Details) 64: R45 Summary of Significant Accounting Policies - HTML 31K Principals of Consolidation (Details) 65: R46 Summary of Significant Accounting Policies - HTML 100K Noncontrolling Interests (Details) 66: R47 Summary of Significant Accounting Policies - HTML 45K Dividends and Distributions (Details) 67: R48 Summary of Significant Accounting Policies - Tax HTML 38K Status of Dividends and Distributions (Details) 68: R49 Summary of Significant Accounting Policies - HTML 32K Impairment of Intangible and Long-Lived Assets (Details) 69: R50 Summary of Significant Accounting Policies - HTML 42K Investments in Unconsolidated Entities (Details) 70: R51 Summary of Significant Accounting Policies - Real HTML 37K Estate Loans Receivable (Details) 71: R52 Summary of Significant Accounting Policies - HTML 31K Escrow Revenue (Details) 72: R53 Summary of Significant Accounting Policies - HTML 31K Derivative Instruments (Details) 73: R54 Summary of Significant Accounting Policies - HTML 31K Tenant Receivables, Net (Details) 74: R55 Summary of Significant Accounting Policies - HTML 31K Rental Revenue (Details) 75: R56 Summary of Significant Accounting Policies - New HTML 32K Accounting Pronouncements (Details) 76: R57 Acquisitions and Dispositions - (Details) HTML 62K 77: R58 Acquisitions and Dispositions - 2016 Acquisitions HTML 1.14M (Details) 78: R59 2015 Acquisitions (Details) HTML 799K 79: R60 Acquisitions and Dispositions - Assets Acquired HTML 74K and Liabilities Assumed (Details) 80: R61 Acquisitions and Dispositions - Pro Forma HTML 76K Information (Details) 81: R62 Intangibles - (Details) HTML 50K 82: R63 Intangibles - Carrying Amount of Intangible Assets HTML 64K and Liabilities (Details) 83: R64 Intangibles - Acquired Lease Intangible HTML 51K Amortization (Details) 84: R65 Intangibles - Amortization of Acquired Lease HTML 56K Intangibles (Details) 85: R66 Other Assets - Additional Information (Details) HTML 53K 86: R67 Debt - (Details) HTML 117K 87: R68 Debt - Summary of Debt (Details) HTML 91K 88: R69 Debt - Investment Grade Rating Schedule (Details) HTML 65K 89: R70 Debt - Principal Payments Due on Debt (Details) HTML 49K 90: R71 Derivatives - (Details) HTML 37K 91: R72 Derivatives - Fair Value Interest Rate Swaps HTML 54K (Details) 92: R73 Accrued Expenses and Other Liabilities - (Details) HTML 55K 93: R74 Stock-based Compensation - (Details) HTML 95K 94: R75 Stock-based Compensation - Summary of Non-Vested HTML 57K Restricted Common Shares (Details) 95: R76 Stock-based Compensation - Weighted Average Grant HTML 46K Date Fair Value Assumptions (Details) 96: R77 Stock-based Compensation - Trust Restricted Share HTML 58K Activity (Details) 97: R78 Fair Value Measurements - (Details) HTML 41K 98: R79 Fair Value Measurements - Fair Value Financial HTML 66K Instruments (Details) 99: R80 Tenant Operating Leases - (Details) HTML 44K 100: R81 Rent Expense - (Details) HTML 40K 101: R82 Rent Expense - Schedule of Minimum Lease HTML 58K Obligations (Details) 102: R83 Credit Concentration - (Details) HTML 38K 103: R84 Credit Concentration - Top Five Tenant Credit HTML 50K Concentrations (Details) 104: R85 Credit Concentration - Top Five Geographic HTML 50K Concentrations (Details) 105: R86 Earnings Per Share and Earnings Per Unit - HTML 150K Additional Information (Details) 106: R87 Subsequent Events - Additional Information HTML 79K (Details) 107: R88 Quarterly Data - Additional Information (Details) HTML 97K 108: R89 Schedule Iii - Real Estate and Accumulated HTML 1.58M Depreciation (Details) 109: R90 Schedule Iii - Real Estate and Accumulated HTML 60K Depreciation (Details 2) 111: XML IDEA XML File -- Filing Summary XML 188K 110: EXCEL IDEA Workbook of Financial Reports XLSX 202K 14: EX-101.INS XBRL Instance -- doc-20161231 XML 10.67M 16: EX-101.CAL XBRL Calculations -- doc-20161231_cal XML 341K 17: EX-101.DEF XBRL Definitions -- doc-20161231_def XML 1.76M 18: EX-101.LAB XBRL Labels -- doc-20161231_lab XML 3.32M 19: EX-101.PRE XBRL Presentations -- doc-20161231_pre XML 2.08M 15: EX-101.SCH XBRL Schema -- doc-20161231 XSD 432K 112: ZIP XBRL Zipped Folder -- 0001574540-17-000007-xbrl Zip 661K
Exhibit |
1. | I have reviewed this Annual Report on Form 10-K for the fiscal year ended December 31, 2016, of Physicians Realty Trust; |
2. | Based
on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. | The
registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
a. | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
b. | Designed
such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
c. | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
d. | Disclosed
in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
5. | The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
a. | All
significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
b. | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
Date:
February 24, 2017 | |
Executive Vice President and Chief Financial Officer |
This ‘10-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 2/24/17 | 10-K, 8-K, S-3ASR | ||
For Period end: | 12/31/16 | |||
List all Filings |